Crossmark

The impacts of race and regimens on the efficacy and safety of paclitaxel and platinum combination treatment for patients with advanced non-small cell lung cancer

Crossref DOI link: https://doi.org/10.1007/s00228-021-03129-6

Published Online: 2021-03-29

Published Print: 2021-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zhao, Chenyang

Wang, Fengli

Huang, Jihan

Lv, Yinghua

Yin, Fang

Liu, Hongxia

Zheng, Qingshan

Li, Lujin
Funding

Funding for this research was provided by:

Shanghai S&T Innovation Plan (17401970900)

National Major Science and Technology Projects of China (2018ZX09734005, 2018ZX09711001-009-011, 2018ZX09731016, 2017ZX09304003, 2018ZX10303501)
License Information

Text and Data Mining valid from 2021-03-29

Version of Record valid from 2021-03-29
More Information

Article History

Received: 26 January 2021

Accepted: 22 March 2021

First Online: 29 March 2021

Declarations

:

: Not applicable.

: Not applicable.

: All authors has have consented for publication to the journal.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below